Liquid biopsy technology has been widely embraced in cancer treatments as a way to identify which therapies may work best for patients based on the presence of trace amounts of genetic material in a patient’s bloodstream that are shed by cancer cells.
https://techcrunch.com/2020/02/24/karius-raises-165-million-for-its-liquid-biopsy-technology-identifying-diseases-in-a-drop-of-blood/
https://techcrunch.com/2020/02/24/karius-raises-165-million-for-its-liquid-biopsy-technology-identifying-diseases-in-a-drop-of-blood/